Morgan Advanced Materials plc (MGAM)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 244.00 |
|---|---|
| 52-week range | 179.80 – 294.50 |
| Return, 1 month / 3 months | −6.0% / +9.2% |
| Return, 1 year / 3 years | +23.4% / +24.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 36 |
| Volatility (1 year) | 31.5% |
| Worst drawdown (1 year) | -23.0% |
| Average daily value traded | 267.63M GBX |
| Dividend yield | 7.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Morgan Advanced Materials makes specialised components from ceramics, carbon and composite materials. Its products include ceramic parts, seals, crucibles, thermal insulation and electrical carbon components, supplied to customers in medical, aerospace, defence, energy and industrial equipment markets. The company is based in the United Kingdom and operates manufacturing sites in several countries, serving industrial buyers who need materials that withstand heat, wear, corrosion or electrical stress.
The shares are listed on the London Exchange in UK under the code MGAM, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Morgan Advanced Materials plc (MGAM) trades on the London Exchange in UK. It last closed at GBX 244.00 on 23 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 268 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 23.4% and over the last three months it rose 9.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.8% | ||
| From 52-week high | -15.9% | ||
| Momentum | 77 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 9.2% | ||
| 6-month return | 13.5% | ||
| 12-month return, skipping the last month | 31.3% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.0% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 267.63M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 87 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 7.2% | ||
| Years with dividends | 6 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −14.2% |
|---|---|
| 1 month | −6.0% |
| 3 months | +9.2% |
| 6 months | +13.5% |
| 1 year | +23.4% |
| 3 years | +24.1% |
| 5 years | −10.4% |
Signals
| 50-day / 200-day average | 255.03 / 228.48 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9.48 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Oct 2026 | GBP 0.0540 |
| 9 Apr 2026 | GBP 0.0680 |
| 23 Oct 2025 | GBP 0.0540 |
| 10 Apr 2025 | GBP 0.0680 |
| 24 Oct 2024 | GBP 0.0540 |
| 25 Apr 2024 | GBP 0.0670 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.